Grøndahl C, Hansen T H, Marky-Nielsen K, Ottesen J L, Hyttel P
Health Care Fertility Team, Novo Nordisk A/S, Copenhagen, Denmark.
Hum Reprod. 2000 Dec;15 Suppl 5:3-10. doi: 10.1093/humrep/15.suppl_5.3.
In-vitro studies in mouse oocytes have shown that the C-29 endogenously occurring sterol FF-MAS (follicular fluid meiosis-activating sterol) is a potent inducer of meiotic maturation leading to increased fertilization rates. We have used synthetic FF-MAS to induce meiotic maturation in immature human oocytes aspirated from polycystic ovarian syndrome patients. The patients were asked to give written consent to donate half of their aspirated oocytes to investigate the influence of culture conditions on maturation kinetics. The oocytes were aspirated from follicles 8-12 mm in diameter under ultrasound guidance after initial treatment with a gonadotrophin-releasing hormone agonist and s.c. injections of recombinant FSH for 3 days. The other half of the oocytes remained outside this present study. They were reserved for the patients' benefit and were fertilized with appropriate embryo stages being transferred. Fertilization and transfer were not attempted for the study oocytes. Synthetic sterol FF-MAS was added to the culture media at a concentration of 20 micromol/l and nuclear maturation was compared to a control group of oocytes cultured in media only supplemented with vehicle (TCM-199 supplemented with 0.2% ethanol v/v); thus no additional hormones, growth factors, serum or follicle fluid were added. In 31 cycles, oocytes were randomly allocated to one of seven treatment groups: fixed immediately upon aspiration (0 h group) or after in-vitro maturation culture in the presence or absence of FF-MAS for 22, 30 or 40 h respectively. A total of 81 oocytes were processed for light microscopy. The optimal timing of maturation was observed following 30 h of in-vitro culture, when 67% of FF-MAS-treated oocytes had completed nuclear maturation to the metaphase-II stage compared to 29% in the control group. The maturation time of 30 h appeared significantly superior to both 22 and 40 h, but only in the presence of FF-MAS. Cumulus expansion was most profound in the FF-MAS group after 30 h whereas all oocytes had shed the cumulus investment after 40 h. Our observations indicate that FF-MAS positively influences the absolute frequency and the kinetics of human oocytes undergoing nuclear maturation.
对小鼠卵母细胞的体外研究表明,内源性存在的C - 29甾醇FF - MAS(卵泡液减数分裂激活甾醇)是减数分裂成熟的有效诱导剂,可提高受精率。我们使用合成的FF - MAS诱导从多囊卵巢综合征患者抽吸的未成熟人类卵母细胞减数分裂成熟。患者被要求书面同意捐赠一半抽吸的卵母细胞,以研究培养条件对成熟动力学的影响。在用促性腺激素释放激素激动剂初步治疗并皮下注射重组促卵泡激素3天后,在超声引导下从直径8 - 12毫米的卵泡中抽吸卵母细胞。另一半卵母细胞不在本研究范围内。它们留作患者之用,并进行受精,将合适阶段的胚胎进行移植。本研究的卵母细胞未尝试受精和移植。将合成甾醇FF - MAS以20微摩尔/升的浓度添加到培养基中,并将核成熟情况与仅添加赋形剂(添加0.2%乙醇体积分数的TCM - 199)的培养基中培养的卵母细胞对照组进行比较;因此未添加额外的激素、生长因子、血清或卵泡液。在31个周期中,卵母细胞被随机分配到七个处理组之一:抽吸后立即固定(0小时组)或分别在有或无FF - MAS的情况下进行体外成熟培养22、30或40小时后固定。总共81个卵母细胞进行了光学显微镜检查。体外培养30小时后观察到最佳成熟时间,此时67%经FF - MAS处理的卵母细胞完成核成熟至中期II阶段(对照组为29%)。30小时的成熟时间明显优于22小时和40小时,但仅在有FF - MAS的情况下。30小时后FF - MAS组的卵丘扩展最为显著,而40小时后所有卵母细胞都已脱去卵丘。我们的观察表明,FF - MAS对人类卵母细胞核成熟的绝对频率和动力学有积极影响。